Carmot Therapeutics Inc. was valued at $1.25 billion in May. Half a year later, the company is selling to Swiss drugmaker Roche Holding AG for more than double that amount, fueled by the frenzied demand for obesity medicines.
Investegate |Allianz Glbl Inv Announcements | Allianz Glbl Inv: Top 10 Holdings investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.